The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT): The largest hypertension study ever undertaken: Baseline characteristics

被引：0
|
作者：
Grimm, RH
Davis, BR
Ford, C
Alderman, MH
Black, HR
Cushman, WC
Dequattro, V
Papademetriou, V
机构：
[1] SHAPIRO CTR EVIDENCE BASED MED,MINNEAPOLIS,MN
[2] COORDINATING CTR CLIN TRIALS,HOUSTON,TX
[3] ALBERT EINSTEIN COLL MED,BRONX,NY 10467
[4] RUSH MED COLL,CHICAGO,IL 60612
[5] UNIV TENNESSEE,MEMPHIS,TN
[6] UNIV SO CALIF,LOS ANGELES,CA
[7] MINNEAPOLIS MED RES FDN INC,WASHINGTON,DC
来源：
CIRCULATION | 1997年 / 96卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1542 / 1542
页数：1
相关论文
共 50 条
  • [1] Baseline characteristics of participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Grimm, RH
    Margolis, KL
    Papademetriou, V
    Cushman, WC
    Ford, CE
    Bettencourt, J
    Alderman, MH
    Basile, JN
    Black, HR
    DeQuattro, V
    Eckfeldt, J
    Hawkins, CM
    Perry, HM
    Proschan, M
    HYPERTENSION, 2001, 37 (01) : 19 - 27
  • [2] Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Barzilay, JI
    Jones, CL
    Davis, BR
    Basile, JN
    Goff, DC
    Ciocon, JO
    Sweeney, ME
    Randall, OS
    DIABETES CARE, 2001, 24 (04) : 654 - 658
  • [3] Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT)
    Davis, BR
    Cutler, JA
    Gordon, DJ
    Furberg, CD
    Wright, JT
    Cushman, WC
    Grimm, RH
    LaRosa, J
    Whelton, PK
    Perry, HM
    Alderman, MH
    Ford, CE
    Oparil, S
    Francis, C
    Proschan, M
    Pressel, S
    Black, HR
    Hawkins, CM
    AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (04) : 342 - 360
  • [4] Angioedema in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Piller, L
    Ford, C
    Davis, B
    Nwachuku, C
    Black, H
    Oparil, S
    Gappy, S
    Retta, T
    Probstfield, J
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 92A - 92A
  • [5] Baseline Quality of Life and Risk of Stroke in the ALLHAT Study (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
    Shams, Tanzila
    Auchus, Alexander P.
    Oparil, Suzanne
    Wright, Clinton B.
    Wright, Jackson
    Furlan, Anthony J.
    Sila, Cathy A.
    Davis, Barry R.
    Pressel, Sara
    Yamal, Jose-Miguel
    Einhorn, Paula T.
    Lerner, Alan J.
    STROKE, 2017, 48 (11) : 3078 - +
  • [6] Baseline Quality of Life and Risk of Stroke in the Antihypertensive and Lipid Lowering to Prevent Heart Attack (ALLHAT) Trial
    Shams, Tanzila
    Auchus, Alexander P.
    Oparil, Suzanne
    Wright, Clinton
    Wright, Jackson
    Furlan, Anthony J.
    Sila, Cathy A.
    Davis, Barry
    Pressel, Sara
    Yamal, Jose-Miguel
    Einhorn, Paula
    Cutler, Jeff
    Lerner, Alan J.
    STROKE, 2015, 46
  • [7] THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART-ATTACK TRIAL (ALLHAT) - DESIGN AND INITIAL CHARACTERISTICS
    CUSHMAN, WC
    HYPERTENSION, 1995, 25 (06) : 1356 - 1356
  • [8] Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) - Practical implications
    Oparil, S
    HYPERTENSION, 2003, 41 (05) : 1006 - 1009
  • [9] Antihypertensive and lipid-lowering treatment to prevent heart attack (ALLHAT) trial: Interim results
    Davis, B
    Furberg, CD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (01) : 325 - 325
  • [10] Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Pressel, S
    Davis, BR
    Louis, GT
    Whelton, P
    Adrogue, H
    Egan, D
    Farber, M
    Payne, G
    Probstfield, J
    Ward, H
    CONTROLLED CLINICAL TRIALS, 2001, 22 (06): : 674 - 686
12345